We are live on ! Find out more
DWA

Douglass Winthrop Advisors Portfolio holdings

AUM $5.46B
1-Year Est. Return 11.49%
This Fund
S&P 500
This Quarter Est. Return
+5.86%
1 Year Est. Return
+11.49%
3 Year Est. Return
+66.59%
5 Year Est. Return
+87.07%
10 Year Est. Return
+344%
AUM
$1.35B
AUM Growth
+$80.8M
Cap. Flow
+$16.2M
Cap. Flow %
1.2%
Top 10 Hldgs %
33.07%
Holding
253
New
15
Increased
94
Reduced
59
Closed
19

Top Buys

Rank Stock Value
1
TIF
Tiffany & Co.
TIF
+$18.6M
2
BUD icon
AB InBev
BUD
+$14.8M
3
AAPL icon
Apple
AAPL
+$11.5M
4
ECL icon
Ecolab
ECL
+$9.24M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$4.25M

Sector Composition

Rank Sector Weight
1 Financials 18.77%
2 Consumer Staples 16.27%
3 Industrials 13.04%
4 Healthcare 11.78%
5 Communication Services 10.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRG icon
201
Intuitive Surgical
ISRG
$127B
$246K 0.02%
4,050
TWX
202
DELISTED
Time Warner Inc
TWX
$245K 0.02%
3,782
-1,500
-28% -$105K
RL icon
203
Ralph Lauren
RL
$22.1B
$242K 0.02%
2,175
+175
+9% +$20.7K
MTUS icon
204
Metallus
MTUS
$835M
$241K 0.02%
28,779
CAG icon
205
Conagra Brands
CAG
$7.49B
$236K 0.02%
7,196
WEC icon
206
WEC Energy
WEC
$36.7B
$232K 0.02%
4,512
TYC
207
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
$229K 0.02%
6,852
TXN icon
208
Texas Instruments
TXN
$246B
$219K 0.02%
+4,000
New +$223K
RLYP
209
DELISTED
RELYPSA INC COM
RLYP
$218K 0.02%
+7,700
New +$166K
INCY icon
210
Incyte
INCY
$25.4B
$217K 0.02%
2,000
REGN icon
211
Regeneron Pharmaceuticals
REGN
$73B
$217K 0.02%
+400
New +$217K
MKC icon
212
McCormick & Company Non-Voting
MKC
$14.2B
$214K 0.02%
5,000
DVA icon
213
DaVita
DVA
$15.5B
$212K 0.02%
+3,039
New +$223K
AFL icon
214
Aflac
AFL
$66.1B
$210K 0.02%
7,000
ALL icon
215
Allstate
ALL
$71.3B
$204K 0.02%
+3,292
New +$205K
AON icon
216
Aon
AON
$80.7B
$203K 0.02%
+2,200
New +$205K
LLY icon
217
Eli Lilly
LLY
$1.1T
$202K 0.02%
2,400
-600
-20% -$49.8K
KMI icon
218
Kinder Morgan
KMI
$71.2B
$196K 0.01%
13,107
-3,150
-19% -$75.1K
CG icon
219
Carlyle Group
CG
$16.2B
$182K 0.01%
11,650
-1,000
-8% -$17.8K
CC icon
220
Chemours
CC
$2.46B
$67K 0.01%
12,588
-259
-2% -$1.66K
LCTX icon
221
Lineage Cell Therapeutics
LCTX
$259M
$61K ﹤0.01%
18,585
ABEV icon
222
Ambev
ABEV
$48.2B
$54K ﹤0.01%
12,000
ROX
223
DELISTED
Castle Brands, Inc.
ROX
$25K ﹤0.01%
20,000
GDP
224
DELISTED
GOODRICH PETROLEUM CORP(NEW)
GDP
$15K ﹤0.01%
57,200
KMI.WS
225
DELISTED
Kinder Morgan Inc
KMI.WS
$2K ﹤0.01%
33,200
-1,280
-4% -$611

Similar funds

Douglass Winthrop Advisors's Q4 2015 Portfolio in Review

As of Q4 2015, Douglass Winthrop Advisors held 253 positions worth $1.35B, up 6.4% from $1.27B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Douglass Winthrop Advisors's Q4 2015 filing shows 15 new, 94 increased, 59 reduced and 19 closed positions. Its largest new stake was Macy's: 33,500 shares worth $1.17M. The largest sale was Bausch Health, an estimated $21.1M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Consumer Staples and Industrials.

  • Douglass Winthrop Advisors's largest Q4 2015 buy was Macy's: 33,500 shares worth $1.17M.
  • Douglass Winthrop Advisors added most to Tiffany & Co. in Q4 2015, an estimated $18.6M increase.
  • Douglass Winthrop Advisors's biggest Q4 2015 reduction was PRECISION CASTPARTS CORP, cutting an estimated $15.3M.
  • Douglass Winthrop Advisors fully exited Bausch Health in Q4 2015, selling an estimated $21.1M.
  • Douglass Winthrop Advisors's ten largest holdings make up 33% of its $1.35B portfolio in Q4 2015.
  • Douglass Winthrop Advisors opened 15 new positions and closed 19 in Q4 2015.
  • Douglass Winthrop Advisors's portfolio value rose 6.4% quarter-over-quarter to $1.35B.

Based on Douglass Winthrop Advisors's 13F filing for Q4 2015, filed 25 Jan 2016.